Search by keywords: and/or Explore by tags: Cancer CareCancer Care › Clinical TrialsCancer Care › DiagnosisCancer Care › Diagnosis › PathologyCancer Care › Genetic TestingCancer Care › Integrative MedicineCancer Care › Integrative Medicine › AcupunctureCancer Care › Medical TechnologyCancer Care › Medical Technology › Bone ScanCancer Care › Medical Technology › CTCancer Care › Medical Technology › MRICancer Care › NursingCancer Care › Pain ManagementCancer Care › Palliative CareCancer Care › Patient Care FacilitiesCancer Care › Prediction ToolsCancer Care › PreventionCancer Care › ScreeningCancer Care › Screening › ColonoscopyCancer Care › Screening › MammographyCancer Care › Screening › PSA TestingCancer Care › TreatmentCancer Care › Treatment › Blood & Marrow Stem Cell TransplantationCancer Care › Treatment › Plastic & Reconstructive SurgeryCancer Care › Treatment › Interventional Radiology Cancer Care › Treatment › Robotic SurgeryCancer Care › Treatment › ChemotherapyCancer Care › Treatment › Gene TherapyCancer Care › Treatment › Hormone TherapyCancer Care › Treatment › ImmunotherapyCancer Care › Treatment › Personalized MedicineCancer Care › Treatment › Radiation TherapyCancer Care › Treatment › SurgeryCancer Care › Treatment › Targeted TherapyCounseling & SupportCounseling & Support › CancerSmartCounseling & Support › Cognitive TestingCounseling & Support › PsychiatryCounseling & Support › Sexual HealthCounseling & Support › Social WorkCounseling & Support › Virtual ProgramsEducation & TrainingMiscellaneousMiscellaneous › FacebookMiscellaneous › WebsiteSurvivorshipSurvivorship › BridgesResearchResearch › Cancer Genetics & GenomicsResearch › Sloan Kettering InstituteResearch › Cancer Immunotherapy & VaccinesResearch › Cancer MetabolismResearch › CellBased TherapyResearch › Cell Signaling & RegulationResearch › Chemical BiologyResearch › Computational OncologyResearch › Developmental BiologyResearch › Discoveries & AdvancesResearch › Discoveries & Advances › Lab ResearchResearch › Discoveries & Advances › Clinical ResearchResearch › Discoveries & Advances › Health Outcomes, Epidemiology & StatisticsResearch › EpigeneticsResearch › Genome IntegrityResearch › Hematologic MalignanciesResearch › ImagingResearch › ImmunologyResearch › Metastasis & Drug ResistanceResearch › Microbiome & InflammationResearch › Molecular Pathology & DiagnosticsResearch › NanotechnologyResearch › Neuroscience & NeuroOncologyResearch › Solid Tumor OncogenesisResearch › Stem Cell BiologyResearch › Structural BiologyResearch › Systems BiologyResearch › Targeted TherapyResearch › Tumor MicroenvironmentGivingGiving › Donating BloodGiving › FundraisingGiving › The Society of MSKCCGiving › Volunteering Upcoming Seminars and Events View upcoming seminars and events. Learn more 16 News Items found In the Lab Bull’s-Eye: Imaging Technology Could Confirm When a Drug Is Going to the Right Place Friday, October 25, 2019 Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth. Feature An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective Friday, April 5, 2019 Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective. Roundup Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting Monday, December 3, 2018 Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology. Finding Gut Microbes May Protect People Having Bone Marrow Transplants Sunday, December 2, 2018 For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward. In the Clinic Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch Friday, February 2, 2018 A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer. In the Clinic Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects Wednesday, January 31, 2018 The study represents 20 years of research at MSK. In the Clinic CAR T Cell Therapies Are a Growing Area of Research Tuesday, March 31, 2015 Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research. Q&A Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise Friday, January 30, 2015 An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. Finding Immunotherapy Shows Promise for Treating Solid Tumors in the Chest Wednesday, November 19, 2014 A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs. Finding Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs Monday, November 17, 2014 A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors. Decoder What Is Epigenetics? Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. Finding Hsp90: A Very Promising Target for Cancer Therapy Thursday, July 17, 2014 A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors. MSK at ASCO Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting Wednesday, June 4, 2014 Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer. In the Clinic New Trial Advances Cell-Based Immune Therapy for Certain Leukemias Thursday, February 20, 2014 A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment. In the Clinic Cell-Based Immune Therapy Shows Promise in Leukemia Patients Wednesday, March 20, 2013 Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia. In the Clinic Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder Monday, July 16, 2012 Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.